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Kellgren–Lawrence gradingAbstract Introduction: Identifying osteoarthritis (OA) patients at high risk for progression is
important.
Aim of the work: To study the expression pattern of micro RNA-146a (miR-146a), NF-jB/p65
binding activity and serum pentosidine levels in patients with primary knee OA (KOA) in order to
assess their value as potential markers for disease prognosis and severity and to clarify their role in
disease pathogenesis.
Patient and methods: This study was conducted on 36 female patients with primary KOA divided
radiologically into those with moderate KOA and severe KOA as well as 20 controls. The expres-
sion patterns of miR-146a were analyzed using quantitative real time-PCR, NF-jB/p65 binding
activity and serum pentosidine levels determined using ELISA kits.
Results: miR-146a expression levels were signiﬁcantly higher in KOA patients than controls
being signiﬁcantly higher in moderate KOA compared to severe cases. NF-jB/p65 binding activity
and serum pentosidine levels were signiﬁcantly higher in severe KOA patients (0.74 ± 0.06 and
425.2 ± 40.3 pg/ml) compared to moderate cases (0.3 ± 0.03 and 311.4 ± 30 pg/ml) (p< 0.05)
and were higher compared to controls (0.15 ± 0.08 and 257 ± 32.3 pg/ml respectively) (p< 0.05).
Conclusion: This study may emphasize the role of miR-146a expression, and NFKB/p65 binding
activity in primary KOA. Assessment of NFKB/p65 binding activity, miR-146a expression, and
serum pentosidine in primary KOA patients could extend the panel of laboratory tests available
to monitor the severity and progress of the disease and might beneﬁt as markers for detection of
patients with high risk for disease progression; and hence to be a novel therapeutic target to inhibit
cartilage destruction.
 2016 Publishing services provided by Elsevier B.V. on behalf of Egyptian Society of Rheumatic
Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Osteoarthritis (OA) is a complex and multifaceted disease,
characterized by the degradation of articular cartilage and
joint inﬂammation [1]. OA is associated with age-related loss
of the homeostatic balance between cartilage degradation
and repair mechanisms [2]. Several biomarkers are involved
in the pathogenesis of Egyptian patients with Knee OA
(KOA) as interleukin-1b, tumor necrosis factor-a (TNF-a),
matrix metalloproteinase (MMP) [3] and cartilage oligomeric
cartilage protein [4]. Vascular endothelial growth factor and
osteopontin notably correlated with radiological changes of
KOA [5,6]. Understanding the molecular mechanisms involved
in the maintenance and destruction of articular cartilage can
lead to the identiﬁcation of novel therapeutic targets for OA.
MicroRNAs (miRNAs) are a type of small, noncoding,
single-stranded RNAs that can post-transcriptionally down-
regulate gene expression [7] and are vital regulatory molecules
involved in the pathogenesis of immune and inﬂammatory dis-
eases [8]. Among these conserved miRNAs, miR-146a is well
known for its regulation of the immune response and inﬂam-
mation [9]. MiR-146a is induced upon the activation of toll-
like receptor 4 in the NF-jB-dependent signaling pathway,
leading to the down regulation of IL-1 receptor-associated
kinase 1 and TNF-receptor-associated factor 6 [10].
Nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-jB) is a protein complex that controls DNA tran-
scription. It plays a crucial role in immune and inﬂammatory
responses, through the regulation of various genes encoded
proinﬂammatory cytokines, adhesion molecules, chemokines,
inducible enzymes and apoptosis [11]. Induction of expression
of miR-146a is NF-jB dependent [10]. NF-jB is kept inactive
in the cytoplasm by binding to one of the inhibitory proteins
called IKB-a, IKB-b, IKB-e, p105, and p100. As a result of
the phosphorylation and subsequent degradation of the inhibi-
tory subunits, NF-jB translocates to the nucleus, binds to jB
sites, and regulates target genes. Due to its strong transcrip-
tional activity, the p65 subunit of NF-jB (NF-jB/p65) is
responsible for most of NF-jB’s transcriptional activity [12].
NF-jB signaling not only plays a central role in the pro-
inﬂammatory stress-related response of chondrocytes to
extra- and intra-cellular insults, but also controls their differ-
entiation program [11].
The incidence of OA increases strongly with age: >50%
of the population over 60 years of age shows signs of carti-
lage damage [13]. One of the major age-related changes in
articular cartilage is the accumulation of advanced glycation
endproducts (AGEs) [14]. AGEs are modiﬁcations of proteins
or lipids that are produced through a non-enzymatic reaction
between reducing sugars and free amino groups of proteins,
lipids, or nucleic acids [15]. Excessive levels of AGEs are
pathogenic, resulting in elevated oxidative stress and
inﬂammation [16]. Pentosidine, one of the few chemically
characterized AGEs is used as a marker for the process of
non-enzymatic glycation.
The aim of this study is to clarify the role of miR-146a gene
expression, NF-jB/p65 binding activity and pentosidine serum
levels in knee OA (KOA) patients in order to assess their value
as potential markers for disease prognosis and severity and to
elucidate their role in disease pathogenesis.2. Patients and methods
This study was carried out on 56 subjects; including 20 healthy
females aged 38–58 years representing control and 36 female
patients with primary KOA aged 37–63 years presented to
Outpatient Clinic of the Physical Medicine and Rheumatology
Department, Tanta University Hospitals, Egypt. The diagnosis
of KOA was based on the American College of Rheumatology
criteria [17]. Those patients were classiﬁed according to the
Kellgren–Lawrence (KL) grade [18] into Moderate OA (grade
3) (n= 18) and severe OA (grade 4) (n= 18). Approval was
obtained from the local research ethics committee, and written
informed consent was obtained from each participant.
In all the participants, demographic and clinical informa-
tion was recorded and body mass index (BMI) calculated.
OA patients were subjected to complete history taking includ-
ing disease onset, and duration and treatment history. Subjects
excluded from this study were with other etiologies causing
knee arthritis or causing secondary knee OA such as inﬂamma-
tory arthritis (rheumatoid, gout, pseudo gout), posttraumatic
or post septic arthritis, also control subjects who had any signs
or symptoms of arthritis or joint diseases.
The severity of OA was evaluated according to the KL
grade classiﬁcation [18] and only patients with KL grades of
2 or higher were included. Participants were radiographically
classiﬁed into three groups: normal (KL grade 0 or 1), moder-
ate (grade 2) and severe (grade 3 or 4). Controls were deﬁned
as not having any radiographic knee OA as indicated by KL
grade 0 for both knees.
After 12 h of overnight fasting, 7 ml of venous blood sam-
ples was transferred slowly into a dry sterile centrifuge tube,
allowed to clot at room temperature, centrifuged at
2000 rpm for 10 min and serum was separated and stored at
70 C until the time of analysis.
miR-146a expression levels were estimated in peripheral
blood mononuclear cells (PBMCs) using real-time PCR.
PBMCs were prepared by density gradient centrifugation using
Ficoll–Hypaque (Pharmacia, Uppsala, Sweden). Brieﬂy, hep-
arinised blood was carefully layered on Ficoll, and PBMC
were harvested from the white interphase after centrifugation
for 30 min at 400g, at room temperature and washed with
phosphate buffered saline (PBS). The PBMCs samples were
stored at 80 C till the samples were further processed for
RNA isolation. Total RNA was isolated from frozen PBMC
samples by Qiagen RNeasy Mini Kit according to the protocol
supplied by the manufacturer. RNA was eluted and its concen-
tration was measured spectrophotometrically (at 280 nm).
The extracted RNA was reverse transcribed into cDNA
using high capacity cDNA synthesis kit, Applied Biosystems.
Ten ll of random hexamer primers (Roche, Mannheim,
Germany) was added to 21 ll of RNA which was denatured
for 5 min in the thermal cycler (Biometra, USA). The RNA-
primer mixture was cooled to 4 C. The cDNA master mix
was prepared (5 ll of ﬁrst strand buffer, 10 mM of dNTPs,
1 ll of RNase inhibitor, 1 ll of reverse transcriptase Super-
scriptTM II-RT enzyme and 10 ll of DEPC treated water)
according to the kit protocol and was added to each sample.
The total volume of the cDNA master mix was 19 ll for each
sample. This was added to 31 ll RNA-primer mixtures result-
ing in a reaction volume of 50 ll, which was then incubated in
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inactivation of enzymes at 95 C for 10 min, and ﬁnally cooled
at 4 C. The RNA was reverse transcribed into cDNA which
was then stored at 20 C. One ll of the cDNA was added
to a 20 ll reaction mixture of the QuantiTect SYBR-Green
PCR kit (Qiagen) and 0.5 lM from the speciﬁc primer pair
for human microRNA-149a. This cDNA was then ampliﬁed
using the step one instrument (Applied Biosystems, USA). A
control reaction without a DNA template was performed in
parallel to detect genomic DNA contamination. Primer
sequences speciﬁc for miR-146a were designed according to
Nakasa et al. [19] as follows: sense, 50-CAG-CTG-CAT-TG
G-ATTTAC-CA-30 and anti-sense, 50-GCC-TGA-GAC-TCT-
GCC-TTC-TG-30. Primers for U6 snRNA were included as
an endogenous control [20] sense, 50 CGCTTC GGCAGCA-
CATATAC 30, and antisense, 50 TTCACGAATTTGCGTGT-
CAT 30. The determination of the relative levels of gene
expression was performed using the cycle threshold) DDCt)
method and normalized to the reference gene U6 snRNA.
NFjB/p65 DNA binding activity was estimated in the
PBMCS nuclear extracts using transcription factor binding
assay kit. Nuclear proteins were isolated from PBMC extract
using Nuclear Extract kit (Cat#40010, Active Motif, Carlsbad,
CA, USA) according to the protocol of the manufacturer.
Brieﬂy, the sample was placed in 0.8 mL of ice-cold hypotonic
buffer [10 mmol/L HEPES (pH 7.9), 10 mL KCL, 0.1 mmol/L
EDTA, 0.1 mmol/L ethylene glycol tetraacetic acid, 1 mmol/L
DTT; Protease inhibitors (aprotinin, pepstatin and leupeptin,
10 mg/L each)]. The homogenates were incubated on ice for
20 min, vortexed for 20 s after adding 50 lL of 10% Nonidet
p-40, and then centrifuged for 1 min at 4 C in an Eppendorf
centrifuge. Supernatants were decanted, the nuclear pellets
after a single wash with hypotonic buffer without Nonidet
p-40 were suspended in an ice-cold hypertonic buffer
(20 mmol/L HEPES (pH 7.9), 0.4 mol/L NaCl, 1 mmol/L
EDTA, 1 mmol/L DTT; Protease inhibitors), incubated on
ice for 30 min at 4 C, mixed frequently and centrifuged for
15 min at 4 C. The supernatants were collected as nuclear
extracts and stored at 70 C [21]. Concentrations of total
proteins in the samples were determined according to the
method of Bradford (#Cat No. 500-0006, Bio-Rad Protein
Assay) [22].
NFjB/p65 DNA-binding activity was evaluated using the
ELISA-based TransAM NFjB/p65 protein assay (#Cat
No. 40096, Active Motif, Carlsbad, CA, USA), following the
protocol of the manufacturer. In this commercial kit, a
duplexed NF-jB oligonucleotide containing a jB consensus
sequence is attached to the surface of 96-well plates. Activated
NF-jB dimers in 20 lg nuclear extract bound to the attached
oligonucleotide are speciﬁcally and quantitatively detected by
subsequent incubation with antibodies against the activated
forms of NFjB/p65 followed by an enzyme-linked (horserad-
ish peroxidase) secondary antibody for colorimetric scoring
[23]. The absorbance was measured on an ELISA reader at
450 nm with a reference wavelength of 655 nm.
Serum pentosidine levels were measured using sandwich
ELISA kit (Cat# CEA264Ge, USCNK Life Science Inc., Wu
Han, China), according to the manufacturer’s protocol.
Statistical analysis: it was performed using SPSS version 15.
Most data are expressed as the mean ± SD. One-way analysis
of variance (ANOVA) followed by Tukey’s post hoc analysis
was used to compare gene expression levels among threegroups. The correlation between the studied clinical and bio-
chemical parameter was calculated using Pearson’s correlation
coefﬁcient. p values of <0.05 were considered statistically
signiﬁcant.
3. Results
Comparison among the KOA patients (moderate and severe)
and controls regarding age, BMI and studied parameters is
demonstrated in Table 1. There were no signiﬁcant differences
between patients with severe and moderate OA regarding age
or BMI (p> 0.05). Of note, miR-146a expression levels were
signiﬁcantly higher in patients with moderate compared to
those with severe OA (p< 0.05) as shown in Fig. 1. In severe
OA, NFKB/P65 binding activity and serum pentosidine levels
(0.74 ± 0.06, 425.22 ± 40.28 pg/ml, respectively) were signiﬁ-
cantly higher than in moderate OA (0.3 ± 0.03, 311.4
± 30.01 pg/ml, respectively) and in control (0.15 ± 0.08,
257 ± 32.26 pg/ml, respectively) (p< 0.05).
Correlations of the studied parameters with age, BMI and
with each other in different grades of OA are presented in
Table 2. The relative expression of miR-146a showed a signif-
icant positive correlation with age and BMI (r= 0.72 and 0.75
respectively <0.05), but a signiﬁcant negative correlation with
NFKB/P65 binding activity (r= 0.47, p< 0.05). On the
other hand, circulating pentosidine levels exhibited signiﬁcant
positive correlations with age and NFKB/P65 binding activity
(r= 0.39 and 0.69 respectively, p< 0.05).
Receiver operating characteristics (ROC) analysis was used
to assess the diagnostic value of NFKB/P65 binding activity
and serum pentosidine levels and to identify their optimal
cut off values. The area under the curve can range from 0.5
to 1 and diagnostic tests that approach 1 indicate a perfect dis-
criminator. The optimal cut off value of NFKB/P65 binding
activity was 0.13, the sensitivity at this cut off point was
100%, the speciﬁcity was 95%, the positive predictive value
was 97.3% and the negative predictive value was 100% and
the area covered was 0.95. Serum pentosidine monitoring
revealed a sensitivity of 75%, speciﬁcity of 100%, positive pre-
dictive value of 100%, negative predictive value of 69%, and
an accuracy of 0.928 at an optimal cut off value of 300 pg/
ml (Table 3, Fig. 2).4. Discussion
Multiple mechanisms are implicated in the development of pri-
mary OA, in which genetic and epigenetic factors appear to
interact with environmental factors and age to initiate the dis-
ease and stimulate its progression. A potential link between
microRNA and several human diseases has been examined
[24], however; its contribution to the molecular pathogenesis
of primary OA is not fully elucidated. The current study
revealed that the expression levels of miR-146a in OA patients
are signiﬁcantly higher compared to controls being highly
expressed in early-stage OA which gradually decreases as OA
progresses.
In this context, Yamasaki et al. [25] have demonstrated that
miR-146 is highly expressed in low-grade OA cartilage, and
that its expression is induced by interleukin (IL)-1b stimula-
tion. Synovitis occurs in OA, where circulating PBMCs
accumulate in the OA synovium resulting in the production
Table 1 Age, body mass index, nuclear factor kappa B/p65 subunit binding activity and serum pentosidine of the knee osteoarthritis
patients (moderate and severe OA) and control.
Variables/Groups Control (n= 20) KOA patients (n= 36) F value
Moderate OA (n= 18) Severe OA (n= 18)
Age (years) 43.45 ± 8.65 69.11 ± 9.32b 66.44 ± 12.14b 37.6a
BMI 22.6 ± 2.42 24.55 ± 3.07b 25.66 ± 5.05b 3.4a
NFKB/P65 activity 0.15 ± 0.08 0.30 ± 0.03b 0.74 ± 0.06b,c 139.2a
Pentosidine (pg/ml) 257 ± 32.3 311.4 ± 30.0b 425.2 ± 40.3b,c 116.6a
Values are expressed as mean ± SD.
BMI, body mass index; NFKB/p65: nuclear factor kappa B/p65 subunit.
a Signiﬁcant at p< 0.05.
b Signiﬁcant as compared to the control.
c Signiﬁcant as compared to the moderate OA.
Figure 1 miR-146a expression in KOA patients and controls.
#Signiﬁcant compared to control at p< 0.05; @signiﬁcant com-
pared to moderate OA at p< 0.05.
Table 2 Correlation of the studied parameters (miRNA-146a
expression, NFKB/P65 and serum pentosidine) with age, body
mass index and each other.
Studied parameters r
miR-146a expression with
NFKB/P65 binding activity 0.47a
Serum pentosidine (pg/ml) 0.12
Age (years) 0.72a
BMI 0.75a
NFKB/P65 binding activity with
Serum pentosidine (pg/ml) 0.69a
Age (years) 0.01
BMI 0.17
Serum pentosidine (pg/ml) with
Age (years) 0.39a
BMI 0.21
miR-146a: microRNA-146a, NFKB/p65: nuclear factor kappa
B/p65 subunit.
r= correlation coefﬁcient.
a Signiﬁcant at p< 0.05.
Table 3 The performance characteristics for NFKB/P65
binding activity and serum pentosidine between moderate and
severe KOA patients.
ROC curve between KOA patients and controls
Cutoﬀ Sensitivity Speciﬁcity PPV NPV Accuracy
NFKB/P65 binding activity
>0.60 100 95 97.3 100 0.95
Serum pentosidine (pg/ml)
>360 75 100 100 69 0.93
KOA: knee osteoarthritis, PPV: positive predictive value, NPV:
negative predictive value, NFKB/p65: nuclear factor kappa B/p65
subunit.
322 S.S. Zakaria et al.of pro-inﬂammatory cytokines and degradative enzymes. Two
major cytokines produced by activated synoviocytes, mononu-
clear cells and articular cartilage and involved in the pathogen-
esis of OA, are IL-1b and TNFa. These cytokines play a
prominent role in OA cartilage degeneration through promot-
ing the release of degenerative enzymes such as matrix metal-
loproteinases (MMPs) and aggrecanases, as well as inhibiting
the synthesis of extracellular matrix proteins by chondrocytes.
They can also stimulate chondrocytes and synovial cells to
produce other cytokines and prostaglandin E2, which in turn
diffuse into the synovial ﬂuid thus aggravating joint inﬂamma-
tion [26]. On the other hand, Park et al. [27] proposed that
miR-146, which is induced by IL-1b at the early-stage of
OA, acts as a negative feedback regulator of the innate
immune response by down-regulating two adapter proteins,
TNF receptor-associated factor 6 (TRAF6) and IL-1
receptor-associated kinase 1 (IRAK1), that are crucial for
proinﬂammatory signaling as they mediate receptor signaling
in response to ligands of the TNFa superfamily and inﬂamma-
tory cytokines (IL-1/Toll superfamily) in knee joint synovio-
cytes. Furthermore, miR-146a might play a role in repression
of catabolic factors as MMP13 and ADAMTS-5 (a disintegrinand metalloproteinase with thrombospondin motifs) gene
expression in early OA cartilage. Well in line, Li et al. [28]
reported that transfection of synthetic miR-146a signiﬁcantly
Figure 2 ROC curves for NFKB/P65 binding activity and serum
levels of pentosidine in knee osteoarthritis patients.
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Aggrecan, collagen II) in human knee joint chondrocytes
and regulates inﬂammatory cytokines in synovial cells from
human knee joints. Given these protective effects of miR-
146a, it is tempting to speculate that in late stage OA cartilage
with low expression levels of miR-146a, cartilage degradation
might progress due to loss of miR-146a acting as a repressor
of catabolic signals [29]. Another plausible mechanism for
miR-146a contribution to late stage OA pathogenesis was
assumed by Li et al. [30] who displayed that miR-146a
increased VEGF levels and led to a reduction of cellular
responsiveness to TGF-b and an increase of apoptosis rate in
chondrocytes.
Nuclear factor-kappaB proteins constitute a family of tran-
scription factors that are stimulated by pro-inﬂammatory
cytokines, chemokines, stress-related factors and extracellular
matrix (ECM) degradation products [31]. The present study
showed that DNA binding capacity of the p65 subunit of
NF-jB was signiﬁcantly increased in OA patients than con-
trols; being higher in those with severe OA. Prevailing experi-
mental data from animal models of arthritis, including murine
type II collagen-induced arthritis and rat adjuvant arthritis,
support the essential role of NF-jB on MMP gene expression
and the development of inﬂammatory and histological changes
of arthritis [32]. Noteworthy, NF-jB activation in articular
chondrocytes regulates the expression of many cytokines and
chemokines, adhesion molecules, inﬂammatory mediators,
and several matrix degrading enzymes [33]. NF-jB also inﬂu-
ences the regulated accumulation and remodeling of ECM pro-
teins and has indirect positive effects on downstream
regulators of terminal chondrocyte differentiation. Thus unlike
other signaling pathways the NF-jB activating kinases are
potential NF-jB signaling as not only playing a central role
in the pro-inﬂammatory stress-related responses of chondro-
cytes to extra- and intra-cellular insults, but also in the controlof their differentiation program. Thus unlike other signaling
pathways keeping NF-jB activation under control can be very
important for the design of speciﬁc therapeutics [11].
Concomitantly, our data reported a signiﬁcant negative
correlation between miR-146a expression with NFKB/P65
binding activity. MiR-146a has been implicated as a negative
feedback regulator of NF-jB activation [8]. Regulation of
the inﬂammatory response via a miR-146a-mediated negative
feedback loop is critical for resolution of the NF-jB response
in OA. miR-146a is an important check on the amplitude and
duration of the NF-jB response. In the absence of this micro-
RNA, this response is dysregulated, leading to increased tran-
scription of certain NF-jB-inducible cytokines and chemokine
[34].
Nevertheless, our data revealed that serum pentosidine
levels were signiﬁcantly higher in OA patients; with being
higher in severe than moderate OA patients and exhibited sig-
niﬁcant positive correlations with age and NFKB/P65 binding
activity. This ﬁnding is in accordance with that of Senolt et al.
[16] who reported increased serum levels of pentosidine in
patients with knee OA in comparison to controls, and found
a positive correlation between pentosidine levels and cartilage
oligomeric matrix protein (COMP), a marker of articular car-
tilage damage. Along this line, Vos et al. [14] concluded that
pentosidine correlated with radiographic progression and thus
added to prediction of the burden of osteophyte formation in a
cohort of early knee and/or hip OA. Also, Braun et al. [35]
showed that the levels of urinary pentosidine are related to
the measurements of joint pain, stiffness and disability that
were assessed in patients with hand OA.
This ﬁnding is biologically plausible as age-associated accu-
mulation of AGE products in joint tissues has been shown to
contribute to molecular changes and pathologic alterations in
articular cartilage, which then may be more susceptible to
damage and development of OA [36]. Pentosidine was charac-
terized as a sensitive marker for all AGEs and was demon-
strated to have increased levels in the damaged articular
cartilage [37]. Accumulating evidence corroborates the notion
that AGEs play a crucial role in the development of OA patho-
genesis through several mechanisms. Initially, AGE accumula-
tion makes the tissue more resistant to MMP and thus
decreases tissue turnover [38]. Well in line, Rasheed and Haqqi
[39] demonstrate that AGEs induce endoplasmic reticulum
stress and stimulate the expression of cyclooxygenase-2
through p38-MAPK and NF-jB pathways in human chondro-
cytes. Alternatively, it has been suggested that AGEs induce
Peroxisome proliferator-activated receptor gamma (PPARc)
down-regulation-mediated inﬂammatory signalings and reduc-
tion of collagen II expression in human OA chondrocytes via
toll like receptor 4 (TLR4) and receptor for AGEs (RAGE)
leading to increased cartilage degradation and chondrocyte
hypertrophy in OA cartilage [40]. Of note, our study revealed
that diagnostic accuracy of NF-jB/p65 binding activity was
superior to that of serum pentosidine levels; suggesting its
enormous value as a potential marker for disease progression
in OA patients.
In conclusion, this study may provide important insights
into the clariﬁcation of primary OA pathogenesis; emphasize
the role of miR-146a expression, and NFKB/p65 binding
activity. The assessment of NFKB/p65 binding activity, miR-
146a expression, and serum pentosidine in primary OA
patients could extend the panel of laboratory tests available
324 S.S. Zakaria et al.to monitor the severity and progress of the disease. They also
could be a suitable target for the development of new thera-
peutic strategies designed to inhibit cartilage destruction in
primary OA.Conflict of interest
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